Publications - Dr. S. Amslinger

38.	A. Mattarei, M. Enzinger, S. Gu, M.M. Karunakaran, B. Kimmel, N. Berner, E.J. Adams, T. Herrmann, S. Amslinger, Chemistry - A European Journal 2017, 23, 11945-11954 A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E )-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1 DOI: 10.1002/chem.201702650
37.	L. Starick, F. Riano, M.M. Karunakaran, V. Kunzmann, J. Li, M. Kreiss, S. Amslinger, E. Scotet, D. Olive, G. De Libero, T. Herrmann, European Journal of Immunology 2017, 47, 982-992 Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation DOI: 10.1002/eji.201646818
36.	L. Brodziak-Jarosz, Y. Fujikawa, D. Pastor-Flores, S. Kasikci, P. Jirásek, S. Pitzl, R.W. Owen, K.D. Klika, C. Gerhäuser, S. Amslinger, T.P. Dick, Molecular Nutrition & Food Research 2016, 60, 737-748 A click chemistry approach identifies target proteins of xanthohumol DOI: 10.1002/mnfr.201500613
35.	B. Jobst, J. Weigl, C. Michl, F. Vivarelli, S. Pinz, S. Amslinger, A. Rascle, Biological Chemistry 2016, 397, 1187-1204 Inhibition of interleukin-3- and interferon- α-induced JAK/STAT signaling by the synthetic α-X-2′,3,4,4′-tetramethoxychalcones α-Br-TMC and α-CF3-TMC DOI: 10.1515/hsz-2016-0148
34.	K.B. Kaufmann, M. Gothwal, N. Schallner, F. Ulbrich, H. Rücker, S. Amslinger, U. Goebel, International Immunopharmacology 2016, 35, 99-110 The anti-inflammatory effects of E-α-(p-methoxyphenyl)-2′,3,4,4′-tetramethoxychalcone are mediated via HO-1 induction DOI: 10.1016/j.intimp.2016.03.018
33.	K.B. Kaufmann, N. Al-Rifai, F. Ulbrich, N. Schallner, H. Rücker, M. Enzinger, H. Petkes, S. Pitzl, U. Goebel, S. Amslinger, PLoS ONE 2015, 10, e0142932 The Cytoprotective Effects of E-α-(4-Methoxyphenyl)-2’,3,4,4'-Tetramethoxychalcone (E-α-p-OMe-C6H4-TMC)-A Novel and Non-Cytotoxic HO-1 Inducer DOI: 10.1371/journal.pone.0142932
32.	H. Rücker, N. Al-Rifai, A. Rascle, E. Gottfried, L. Brodziak-Jarosz, C. Gerhäuser, T.P. Dick, S. Amslinger, Org. Biomol. Chem. 2015, 13, 3040-3047 Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site DOI: 10.1039/C4OB02301C
31.	H. Rücker, S. Amslinger, Free Radic. Biol. Med. 2015, 78, 135-146 Identification of heme oxygenase-1 stimulators by a convenient ELISA-based bilirubin quantification assay
30.	P. Jirásek, S. Amslinger, J. Heilmann, J. Nat. Prod. 2014, 77, 2206-2217 Synthesis of Natural and Non-natural Curcuminoids and their Neuroprotective Activity against Glutamate-induced Oxidative Stress in HT-22 Cells DOI: 10.1021/np500396y
29.	S. Pinz, S. Unser, S. Brueggemann, E. Besl, N. Al-Rifai, H. Petkes, S. Amslinger, A. Rascle, PLoS ONE 2014, 9, e90275 The Synthetic alpha-Bromo-2’,3,4,4’-tetramethoxychalcone (alpha-Br-TMC) Inhibits the JAK/STAT Signaling Pathway DOI: 10.1371/journal.pone.0090275
28.	F. Riaño, M.M. Karunakaran, L. Starick, J. Li, C.J. Scholz, V. Kunzmann, D. Olive, S. Amslinger, T. Herrmann, Eur. J. Immunol. 2014, 44, 2571-2576 Vgamma9Vdelta2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromo¬some 6 DOI: 10.1002/eji.201444712
27.	N. Al-Rifai, H. Rücker, S. Amslinger, Chem. Eur. J. 2013, 19, 15384-15395 Opening or Closing the Lock? - When Reactivity is the Key to Biological Activity. DOI: 10.1002/chem.201302117
26.	S. Amslinger, ChemMedChem 2013, 8, 1416-1417 Drug Discovery from Natural Products. Edited by Olga Genilloud and Francisca Vicente. DOI: 10.1002/cmdc.201300158
25.	S. Amslinger, N. Al-Rifai, K. Winter, K. Wörmann, R. Scholz, P. Baumeister, M. Wild, Organic & Biomolecular Chemistry 2013, 11, 549-554 Reactivity Assessment of Chalcones by a Kinetic Thiol Assay DOI: 10.1039/C2OB27163J
24.	A. Kreuzer, S. Kerres, T. Ertl, H. Rücker, S. Amslinger, O. Reiser, Org. Lett. 2013, 15, 3420-3423 Asymmetric Synthesis of both Enantiomers of Arteludovicinolide A DOI: 10.1021/ol401473v

Publications Dr. Sabine Amslinger

Research Group Amslinger